Showing posts with label improves survival rates in patients with hepatocellular carcinoma. Show all posts
Showing posts with label improves survival rates in patients with hepatocellular carcinoma. Show all posts
Tuesday, March 28, 2017

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

›
 In continuation of my update on Regorafenib Oral multikinase inhibitor regorafenib achieves significantly improved survival r...